This content is machine translated Metastatic colorectal cancer Which first-line therapy for patients with wild-type RAS? At this year’s ESMO Congress in Madrid, treatment options for metastatic colorectal cancer were also discussed. Is there an optimal strategy for patients with a wild-type RAS mutation, and would…
View Post 2 min This content is machine translated RAINBOW Study New standard in the second line? Drugs that are well established in first-line advanced gastric cancer continue to achieve relatively poor survival prognoses in second-line settings. A new study (RAINBOW) now demonstrates the efficacy of ramucirumab…
View Post 2 min This content is machine translated Glioblastoma Moving forward with combined forces Considering that glioblastomas are among the most common and malignant brain tumors and have a very poor prognosis, optimizations of the current therapy are urgently needed. Two publications are attracting…
View Post 2 min This content is machine translated Breast Cancer Proliferation stimulated by soy? There are several epidemiological studies linking soy to a reduced risk of breast cancer or recurrence. At the same time, the phytoestrogens contained in soy, genistein and daidzein, achieve a…
View Post 2 min This content is machine translated Cohort study What is the risk of tumor recurrence with arthritis therapy? TNF inhibition has many benefits in rheumatoid arthritis, but it may also be associated with an increased risk of tumor recurrence. A study of former breast cancer patients seeks to…
View Post 6 min This content is machine translated Hot Line Sessions Which studies were “hot” this year? The Hot Line Sessions are traditionally the best-attended sessions at the ESC Congress, as they present new results of practice-relevant and potentially practice-changing studies from the entire field of cardiology…
View Post 2 min This content is machine translated Glioblastoma and brain metastases Immune system can be harnessed A study at the ESMO Symposium in Geneva shows: Brain metastases have dense concentrations of tumor-infiltrating lymphocytes, i.e., an immune-active environment. Second, both primary and secondary brain carcinomas cause high…
View Post 8 min This content is machine translated Cholesterol Management Impressive results of PCSK9 inhibitors Cholesterol management was the subject of discussion at the Prevention Summit at the University Hospital Zurich. The new lipid guidelines from the AHA/ACC are generating a lot of criticism. This…
View Post 7 min This content is machine translated Skin Cancer Congress Research projects with exciting implications The 24th German Skin Cancer Congress took place in Frankfurt am Main from September 11-13, 2014. In the following, some interesting casuistics, cohort, retro- and prospective studies from different German…
View Post 2 min This content is machine translated Cancer and stroke Retrospective study offers little hope for stroke patients with cancer The aim of a new study was to find out how often and in what way recurrent thromboembolic events present after acute ischemic stroke. This only involved stroke patients who…
View Post 2 min This content is machine translated Cancer patients with diabetes Metformin against cancer? There is increasing evidence from epidemiological studies and scientific research that metformin may have an antitumor effect. However, whether the drug improves survival in cancer patients with diabetes remains unclear…
